This content is from: Home

Bayer takes patent linkage case to India's Supreme Court

India's Supreme Court will hear an appeal by German drug maker Bayer in a case that aims to link the country's IP office and its drug regulator

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial